Navigation Links
Catheter Ablation Effective in Treating Atrial Fibrillation
Date:5/14/2009

Burning faulty tissue better than meds for irregular heartbeat, study suggests

THURSDAY, May 14 (HealthDay News) -- Treating an irregular heartbeat by searing faulty heart tissue may be more effective than treating with medication, a new study shows.

Nearly two-thirds of study participants with atrial fibrillation experienced no such condition-related symptoms one year after having a catheter ablation, a procedure in which heart tissue responsible for the erratic electrical signals throwing off the organ's pumping rhythm is burned and destroyed. Only 17 percent of those in the study treated for the condition with medications reported being arrhythmia-free in the same period.

Those who had the surgical procedure also said they experienced a great improvement in their quality of life.

The international study's 167 participants, all of whom had previously been unable to control the condition with medication alone, had been randomly assigned to either have the heart procedure or be treated for it with medications, according to the research, lead by Dr. David Wilber, director of the Cardiovascular Institute at Loyola University Stritch School of Medicine, in Maywood, Ill.

Wilber was scheduled to present his team's findings Thursday at the Heart Rhythm Society's annual meeting in Boston. The study was funded by Biosense Webster, maker of the ThermoCool catheter used in the trial, and Wilber is a consultant to the company.

More than 2 million Americans have atrial fibrillation, making it the most common of heart rhythm disorders. The electrical signals to the heart become irregular, causing the organ's upper chambers to pump out of rhythm. The condition can cause heart palpitations, dizziness, fatigue, shortness of breath and fainting that lead to a person having a lack of energy, feeling of weakness and a poor quality of life. It can also lead to stroke and heart failure.

Doctors often first prescribe beta blockers, calcium channel blockers, flecainide or propafenone to try to improve the condition before resorting to surgical options such as installing a pacemaker or catheter ablation.

In catheter ablation, doctors guide a thin flexible tube through blood vessels to the heart. Radiofrequency energy directed from the tube's tip heats and destroys the tissue causing the bad electrical signals. The procedure's risks include creating fluid in the lungs or around the heart, bleeding, clots and stroke.

Another study, involving about 3,000 atrial fibrillation patients who will be followed for three years, will try to determine whether those who have catheter ablation live longer those using medication for the condition, according to background information in a Loyola University news release on the study.

More information

The American Heart Association has more about atrial fibrillation.



-- Kevin McKeever



SOURCE: Loyola University Health System, news release, May 14, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
2. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
3. Catheter angiography may be an unnecessary follow-up to CT angiography
4. Massive necrosis after trans-catheter treatment is more common in the presence of tumor capsule
5. Catheter chaos: Hospitals lag in preventing common infection
6. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
7. Balloon catheter-based sinus surgery radiation exposure very low, safe
8. St. Davids Medical Center First in Texas to Implement Visually Guided Catheter Ablation for Atrial Fibrillation
9. Led by Cardiovascular Applications, Double Digit Growth Expected for Catheter Sales
10. Catheter repair of mitral valve improves heart size, symptoms
11. Verathon(R) Offers Enhanced BladderScan(R) Instrument as Part of Continued Program to Eliminate Unnecessary Catheterizations, Decrease Urinary Tract Infections and Assist in Hospital Infection Control
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Catheter Ablation Effective in Treating Atrial Fibrillation
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology: